Acquisition of GFP expressing pulmonary artery endothelial cells - covid-19 action
Ended Purchase Order Awarded
- Contract number
- 75N95022P00235
- Awardee
-
Angio-Proteomie LLC UEI RVNJD3A1BKV7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,410
Award facts
- Opportunity
-
- 75N95022Q00185 Solicitation number
- Contract value 100% obligated
- $19,410.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02215, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95022P00235?
75N95022P00235 was awarded to Angio-Proteomie LLC by National Institute on Drug Abuse (National Institutes of Health) on April 15, 2022.
How much is contract 75N95022P00235 worth?
The government has obligated $19,410 on 75N95022P00235.
Which agency awarded contract 75N95022P00235?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00235, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95022P00235 competed?
The extent of competition for 75N95022P00235 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award